(NICE) Nice - Ratings and Ratios
CXone,Enlighten,Xceed,Evidencentral,X-Sight
NICE EPS (Earnings per Share)
NICE Revenue
Description: NICE Nice
NICE Ltd ADR (NASDAQ:NICE) is a software company that provides cloud-based AI-driven solutions for customer engagement, digital evidence management, and financial crime compliance. Their product suite includes CXone, Enlighten, and X-Sight, which are designed to help organizations automate customer interactions, detect and prevent financial crimes, and manage digital evidence.
From a business perspective, NICE has a strong presence in the application software industry, with a diverse customer base across various sectors. Their solutions are designed to address specific pain points, such as improving customer experience, reducing financial crime risk, and enhancing public safety. With a global footprint and a strong research and development capability, NICE is well-positioned to capitalize on the growing demand for AI-driven digital business solutions.
Some key performance indicators (KPIs) to consider when evaluating NICE include revenue growth, customer acquisition and retention rates, and the percentage of revenue derived from cloud-based subscriptions. Additionally, metrics such as gross margin, operating expenses as a percentage of revenue, and return on equity (RoE) can provide insights into the companys profitability and operational efficiency. NICEs RoE of 13.19% suggests a relatively stable and profitable business model.
To further assess NICEs investment potential, its essential to analyze its financial statements, including revenue and profit margins, as well as its cash flow generation capabilities. A review of the companys management team, corporate governance, and industry trends can also provide valuable context. With a market capitalization of $10.76B, NICE is a mid-cap stock with a relatively stable industry profile, which may appeal to investors seeking exposure to the technology sector.
NICE Stock Overview
| Market Cap in USD | 8,805m |
| Sub-Industry | Application Software |
| IPO / Inception | 1996-01-24 |
NICE Stock Ratings
| Growth Rating | -57.9% |
| Fundamental | 84.4% |
| Dividend Rating | 6.67% |
| Return 12m vs S&P 500 | -25.4% |
| Analyst Rating | 4.33 of 5 |
NICE Dividends
Currently no dividends paidNICE Growth Ratios
| Growth Correlation 3m | -83.5% |
| Growth Correlation 12m | -62.5% |
| Growth Correlation 5y | -79.9% |
| CAGR 5y | -10.75% |
| CAGR/Max DD 3y | -0.21 |
| CAGR/Mean DD 3y | -0.47 |
| Sharpe Ratio 12m | 0.63 |
| Alpha | -19.24 |
| Beta | 0.204 |
| Volatility | 33.48% |
| Current Volume | 525.9k |
| Average Volume 20d | 571.4k |
| Stop Loss | 138.8 (-3.1%) |
| Signal | 0.84 |
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income (537.1m TTM) > 0 and > 6% of Revenue (6% = 170.3m TTM) |
| FCFTA 0.12 (>2.0%) and ΔFCFTA 0.02pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 40.62% (prev 53.46%; Δ -12.84pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.14 (>3.0%) and CFO 754.9m > Net Income 537.1m (YES >=105%, WARN >=100%) |
| Net Debt (3.98m) to EBITDA (791.6m) ratio: 0.01 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.83 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (63.2m) change vs 12m ago -4.02% (target <= -2.0% for YES) |
| Gross Margin 67.03% (prev 67.06%; Δ -0.03pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 54.79% (prev 50.44%; Δ 4.35pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 98.48 (EBITDA TTM 791.6m / Interest Expense TTM 6.11m) >= 6 (WARN >= 3) |
Altman Z'' 5.63
| (A) 0.22 = (Total Current Assets 2.54b - Total Current Liabilities 1.38b) / Total Assets 5.31b |
| (B) 0.51 = Retained Earnings (Balance) 2.70b / Total Assets 5.31b |
| (C) 0.12 = EBIT TTM 601.8m / Avg Total Assets 5.18b |
| (D) 1.68 = Book Value of Equity 2.65b / Total Liabilities 1.58b |
| Total Rating: 5.63 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 84.40
| 1. Piotroski 7.0pt = 2.0 |
| 2. FCF Yield 8.42% = 4.21 |
| 3. FCF Margin 23.26% = 5.81 |
| 4. Debt/Equity 0.18 = 2.48 |
| 5. Debt/Ebitda 0.84 = 1.97 |
| 6. ROIC - WACC 4.52% = 5.65 |
| 7. RoE 14.93% = 1.24 |
| 8. Rev. Trend 98.23% = 7.37 |
| 9. EPS Trend 73.15% = 3.66 |
What is the price of NICE shares?
Over the past week, the price has changed by +0.17%, over one month by +7.53%, over three months by -14.58% and over the past year by -11.32%.
Is Nice a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of NICE is around 120.15 USD . This means that NICE is currently overvalued and has a potential downside of -16.09%.
Is NICE a buy, sell or hold?
- Strong Buy: 10
- Buy: 4
- Hold: 4
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the NICE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 200.3 | 39.9% |
| Analysts Target Price | 200.3 | 39.9% |
| ValueRay Target Price | 131.4 | -8.3% |
Last update: 2025-09-12 04:41
NICE Fundamental Data Overview
CCE Cash And Equivalents = 1.63b USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 16.9689
P/E Forward = 10.5485
P/S = 3.1019
P/B = 2.3502
P/EG = 0.8787
Beta = 0.309
Revenue TTM = 2.84b USD
EBIT TTM = 601.8m USD
EBITDA TTM = 791.6m USD
Long Term Debt = 195.4m USD (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 472.2m USD (from shortTermDebt, last quarter)
Debt = 667.6m USD (Calculated: Short Term 472.2m + Long Term 195.4m)
Net Debt = 3.98m USD (from netDebt column, last quarter)
Enterprise Value = 7.84b USD (8.80b + Debt 667.6m - CCE 1.63b)
Interest Coverage Ratio = 98.48 (Ebit TTM 601.8m / Interest Expense TTM 6.11m)
FCF Yield = 8.42% (FCF TTM 660.1m / Enterprise Value 7.84b)
FCF Margin = 23.26% (FCF TTM 660.1m / Revenue TTM 2.84b)
Net Margin = 18.92% (Net Income TTM 537.1m / Revenue TTM 2.84b)
Gross Margin = 67.03% ((Revenue TTM 2.84b - Cost of Revenue TTM 935.8m) / Revenue TTM)
Tobins Q-Ratio = 2.96 (Enterprise Value 7.84b / Book Value Of Equity 2.65b)
Interest Expense / Debt = 0.92% (Interest Expense 6.11m / Debt 667.6m)
Taxrate = 26.82% (162.2m / 604.8m)
NOPAT = 440.4m (EBIT 601.8m * (1 - 26.82%))
Current Ratio = 1.83 (Total Current Assets 2.54b / Total Current Liabilities 1.38b)
Debt / Equity = 0.18 (Debt 667.6m / last Quarter total Stockholder Equity 3.73b)
Debt / EBITDA = 0.84 (Net Debt 3.98m / EBITDA 791.6m)
Debt / FCF = 1.01 (Debt 667.6m / FCF TTM 660.1m)
Total Stockholder Equity = 3.60b (last 4 quarters mean)
RoA = 10.12% (Net Income 537.1m, Total Assets 5.31b )
RoE = 14.93% (Net Income TTM 537.1m / Total Stockholder Equity 3.60b)
RoCE = 15.87% (Ebit 601.8m / (Equity 3.60b + L.T.Debt 195.4m))
RoIC = 10.86% (NOPAT 440.4m / Invested Capital 4.06b)
WACC = 6.34% (E(8.80b)/V(9.47b) * Re(6.77%)) + (D(667.6m)/V(9.47b) * Rd(0.92%) * (1-Tc(0.27)))
Shares Correlation 3-Years: -72.73 | Cagr: -0.45%
Discount Rate = 6.77% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 81.43% ; FCFE base≈646.8m ; Y1≈798.0m ; Y5≈1.36b
Fair Price DCF = 375.0 (DCF Value 23.16b / Shares Outstanding 61.7m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 73.15 | EPS CAGR: 17.76% | SUE: 0.45 | # QB: False
Revenue Correlation: 98.23 | Revenue CAGR: 10.32%
Additional Sources for NICE Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle